A NEW ORALLY-ACTIVE OXYTOCIN ANTAGONIST

被引：0
|
作者：
PETTIBONE, DJ
CLINESCHMIDT, BV
KISHEL, M
LIS, EV
REISS, DR
WOYDEN, CJ
BOCK, MG
CHIU, SHL
EVANS, BE
FREIDINGER, RM
HOBBS, DW
KAUFMAN, MJ
THOMPSON, KL
VEBER, DF
WILLIAMS, PD
COOK, MJ
HALUSKA, GJ
NOVY, MJ
LOWENSOHN, RI
机构：
[1] MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME LTD,W POINT,PA 19486
[3] OREGON REG PRIMATE RES CTR,BEAVERTON,OR 97006
[4] OREGON HLTH SCI UNIV,PORTLAND,OR 97201
来源：
FASEB JOURNAL | 1993年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A478 / A478
页数：1
相关论文
共 50 条
  • [1] L-368,899, A POTENT ORALLY-ACTIVE OXYTOCIN ANTAGONIST FOR POTENTIAL USE IN PRETERM LABOR
    PETTIBONE, DJ
    CLINESCHMIDT, BV
    GUIDOTTI, MT
    LIS, EV
    REISS, DR
    WOYDEN, CJ
    BOCK, MG
    EVANS, BE
    FREIDINGER, RM
    HOBBS, DW
    VEBER, DF
    WILLIAMS, PD
    CHIU, SHL
    THOMPSON, KL
    SCHORN, TW
    SIEGL, PKS
    KAUFMAN, MJ
    CUKIERSKI, MA
    HALUSKA, GJ
    COOK, MJ
    NOVY, MJ
    DRUG DEVELOPMENT RESEARCH, 1993, 30 (03) : 129 - 142
  • [2] IDENTIFICATION OF AN ORALLY ACTIVE, NONPEPTIDYL OXYTOCIN ANTAGONIST
    PETTIBONE, DJ
    CLINESCHMIDT, BV
    KISHEL, MT
    LIS, EV
    REISS, DR
    WOYDEN, CJ
    EVANS, BE
    FREIDINGER, RM
    VEBER, DF
    COOK, MJ
    HALUSKA, GJ
    NOVY, MJ
    LOWENSOHN, RI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (01): : 308 - 314
  • [3] PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    GRAY, GA
    KALINA, B
    LOFFLER, BM
    BURRI, K
    CASSAL, JM
    HIRTH, G
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01): : 228 - 235
  • [4] BIOLOGICAL CHARACTERISTICS OF THE NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST - S-1762
    JUST, M
    HROPOT, M
    JABLONKA, B
    KONIG, W
    STILZ, HU
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1444 - 1444
  • [5] PULMONARY-HYPERTENSION IS DECREASED BY AN ORALLY-ACTIVE ENDOTHELIN-A ANTAGONIST
    RUMSEY, WL
    BERTELSEN, DL
    ABBOTT, BM
    MALLAMACI, MA
    BIALECKI, RA
    CIRCULATION, 1995, 92 (08) : 2052 - 2052
  • [6] ARYL AMIDINES - A NEW CLASS OF POTENT ORALLY-ACTIVE LEUKOTRIENE-B4 ANTAGONIST
    MAIN, AJ
    BARSKY, LI
    MORRISSEY, M
    CADILLA, R
    BOEHM, C
    ZHANG, YC
    SUH, HS
    BOXER, JB
    POWERS, DB
    FUJIMOTO, RA
    DOTI, RA
    HEALY, CT
    SELIGMANN, BE
    UZIELFUSI, S
    JARVIS, MF
    SILLS, MA
    JACKSON, RH
    LIPSON, KE
    CHIN, MH
    PELLAS, TC
    PASTOR, G
    FRYER, LR
    RAYCHAUDHURI, AA
    KOTYUK, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 3 - MEDI
  • [7] DISCOVERY OF THE ORALLY-ACTIVE SULFONAMIDE ET(A) ANTAGONIST BMS-182874
    STEIN, P
    HUNT, J
    BISAHA, S
    CHONG, S
    GIROTRA, R
    KOZLOWSKI, M
    LEE, V
    LLOYD, J
    MITCHELL, C
    MORRISON, R
    MURUGESAN, N
    SCHMIDT, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 146 - MEDI
  • [8] METIAMIDE - AN ORALLY-ACTIVE HISTAMINE H-2-RECEPTOR ANTAGONIST
    BLACK, JW
    DUNCAN, WAM
    EMMETT, JC
    GANELLIN, CR
    HESSELBO, T
    PARSONS, ME
    WYLLIE, JH
    AGENTS AND ACTIONS, 1994, 43 (3-4): : 91 - 96
  • [9] NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS
    SENOKUCHI, K
    NAKAI, H
    NAKAYAMA, Y
    ODAGAKI, Y
    SAKAKI, K
    KATO, M
    MARUYAMA, T
    MIYAZAKI, T
    ITO, H
    KAMIYASU, K
    KIM, S
    KAWAMURA, M
    HAMANAKA, N
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) : 2521 - 2523
  • [10] THE SYNTHESIS AND BIOLOGICAL CHARACTERISTICS OF NEW ORALLY-ACTIVE CEPHEMS
    TERNANSKY, RJ
    JORDAN, CL
    BELL, FW
    SKAGGS, TG
    KASHER, JS
    JOURNAL OF ANTIBIOTICS, 1993, 46 (12): : 1897 - 1900
12345